Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home / Members / Carey Anders
Carey Anders

Carey Anders

  • MD
  • Breast Cancer
  • UNC Breast Center

  • Assistant Professor
  • UNC-Chapel Hill
  • carey_anders@med.unc.edu
  • 919-966-4431
  • 170 Manning Drive, POB room 3119 Chapel Hill, NC 27599

Area of Interest

Dr. Anders is board-certified in both Internal Medicine and Medical Oncology. Her clinical interest is in breast cancer, specifically breast cancer arising in younger women and those who have developed brain metastasis.

Dr. Anders is a translational researcher who is involved in the design of both clinical trials and preclinical, laboratory experiments within the Lineberger Cancer Center. She completed her Hematology-Oncology fellowship at Duke University (2005-2008) during which time she conducted a large-scale genomic analysis of breast cancers arising in younger women when compared to older counterparts. Her interesting results illustrating a unique biology uniting breast tumors arising in a younger host were recently published in the Journal of Clinical Oncology. During her fellowship, she was also instrumental in the design of several Phase II clinical trials for women who had developed brain metastasis from breast cancer - an aggressive complication of advanced disease for which systemic options and clinical trials are currently limited. She has dedicated her laboratory efforts toward understanding the complex biology/signaling pathways inherent to breast cancer-associated brain metastasis which the goal of moving her preclinical findings into the clinical arena. Working within the Perou laboratory, her preclinical studies include (1) a genomic analysis of human tissues in collaboration with the Department of Neurosurgery and UNC Pathology, (2) an investigation of breast cancer cell lines with predilection for central nervous system metastasis, and (3) conducting experiments with a validated brain metastasis animal model allowing the study of novel therapeutics, particularly nanoparticle anticancer agents capable of crossing the blood brain barrier, in collaboration with the Division of Pharmacotherapy and Experimental Therapeutics. She is also an active member in the UNC Multidisciplinary Breast Cancer Clinic treating and enrolling patients in Phase I - III clinical trials on a weekly basis. Finally, she is currently the recipient of the 2008 Cancer and Leukemia Group B Investigator's Award.

Awards and Honors

  • Vanderbilt University
  • Cum Laude graduate, Brody School of Medicine, East Carolina University
  • American Society of Clinical Pathologists Award for Academic Excellence and Achievement, 2000
  • Bakerman Scholarship Award for excellence in scholarship and service, 2001-2002
  • Honors in OB-GYN, Surgery, Family Medicine, Internal Medicine, Psychiatry, and Pediatrics, 2000-2001
  • Alpha Omega Alpha 2002
  • Janet M. Glasgow Memorial Achievement Citation, American Medical Womens Association, 2002
  • Duke University Assistant Chief Resident, Veterans Affairs Hospital, Fall 2004
  • Institutional Committee of Graduate Medical Education (ICGME) Housestaff Representative, 2004-2005
  • Haskel-Schiff Award; Peer-selected for excellence in clinical medicine, 2005
  • Member, American Society of Clinical Oncology, 2005-present
  • Duke Translational Research in Oncology Training (T32) Grant Recipient, 2006-2008
  • Duke Hematology-Oncology Fellows Research Retreat Award, 2007
  • Duke Comprehensive Cancer Centers Annual Meeting Young Investigators Award Recipient, 2007
  •  2007 ASCO Foundation Merit Award
  • 2008 ASCO Foundation Merit Award
  • Cancer and Leukemia Group B (CALGB) Young Investigator Award, 2008-2009
  • Weatherspoon Family Brain Tumor Research Award, 2011